Literature DB >> 16373826

Aberrant signal transduction in pulmonary hypertension.

Kirk B Lane1, Thomas R Blackwell, James Runo, Lisa Wheeler, John A Phillips, James E Loyd.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16373826     DOI： 10.1378/chest.128.6_suppl.564S-a

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.

Authors:  Keytam S Awad; Jason M Elinoff; Shuibang Wang; Salina Gairhe; Gabriela A Ferreyra; Rongman Cai; Junfeng Sun; Michael A Solomon; Robert L Danner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

Review 2.  Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.

Authors:  Soni Savai Pullamsetti; Rajkumar Savai; Werner Seeger; Elena A Goncharova
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

Review 3.  Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series).

Authors:  Keytam S Awad; James D West; Vinicio de Jesus Perez; Margaret MacLean
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 4.  Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension.

Authors:  Cheng-Jun Hu; Hui Zhang; Aya Laux; Soni S Pullamsetti; Kurt R Stenmark
Journal:  J Physiol       Date:  2018-08-07       Impact factor: 5.182

5.  Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.

Authors:  Eric D Austin; John A Phillips; Joy D Cogan; Rizwan Hamid; Chang Yu; Krista C Stanton; Charles A Phillips; Lisa A Wheeler; Ivan M Robbins; John H Newman; James E Loyd
Journal:  Respir Res       Date:  2009-09-28

6.  Long-Term Effect of a Vaccine Targeting Endothelin-1 Receptor Type A in Pulmonary Arterial Hypertension.

Authors:  Yong Dai; Zhihua Qiu; Wenrui Ma; Chang Li; Xiao Chen; Xiaoxiao Song; Zeyang Bai; Dingyang Shi; Jiayu Zheng; Guangwei Pan; Yuhua Liao; Mengyang Liao; Zihua Zhou
Journal:  Front Cardiovasc Med       Date:  2021-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.